Comparison of the Analgesic Effectiveness of Pericapsular Nerve Block and Suprainguinal Fascia Iliac Block Application

NCT06672289 | Not Yet Recruiting DMC

• 1 other identifier: 2024/162
• Study Type: observational
• Target: 60
• Locations: 0 countries
• Sites: N/A

Brief Summary

Suprainguinal Fascia iliac compartment outlet and Pericapsular nerve reduction, which is a routinely successful method for postoperative analgesia in anesthesia practice; the aim is to investigate information regarding postoperative pain level, analgesic consumption, patient satisfaction and discharge time after arm arthroscopy.

Conditions

Hip Surgery

Keywords

hip arthroscopy; PENG block; Suprainguinal Fascia Iliaca Block

Outcome Measures

Primary Outcomes (1)

• Visual Analogue Score

  A Visual Analogue Scale (VAS) is one of the pain rating scales. It is often used in epidemiologic and clinical research to measure the intensity or frequency of various symptoms. For example, the amount of pain that a patient feels ranges across a continuum from none to an extreme amount of pain. From the patient's perspective, this spectrum appears continuous; their pain does not take discrete jumps, as a categorization of none, mild, moderate and severe would suggest the VAS score for grading of pain consists of a 10 centimetres (cm) line with 10 mm (0.01 cm) to each point of the scale and two end-points representing no pain and worst possible pain, where 0 = no pain, 1-3 = mild, 4-6 = moderate and 7-10 = severe pain

  2-3 hours after surgery

Study Arms (2)

Pericapsular Nerve Block (PENG)

Patients will be monitored with routine monitoring under operating room conditions. After the patient's baseline VAS score and vital signs are recorded, patients will be intubated after induction of general anesthesia. After the site is cleaned, pericapsular nerve block (PENG) will be applied under USG guidance. After the procedure, the patient will be transferred to the surgical team for positioning. Blood pressure and pulse values will be recorded after the procedure and at the 30th minute of surgery. After the patients wake up, another anesthesiologist in the recovery unit will rate the pain of patients in both groups on a scale of 0-10, using the Visual Analogue Scale (VAS) to describe their pain intensity. Heart rates and noninvasive blood pressures of patients taken to the recovery unit will be measured and recorded.

Suprainguinal Fascia Iliaca Block (SFIB)

Patients will be monitored with routine monitoring under operating room conditions. After the patient's baseline VAS score and vital signs are recorded, patients will be intubated after induction of general anesthesia. After the site is cleaned, suprainguinal fascia iliaca block (SFIB) will be applied under USG guidance. After the procedure, the patient will be transferred to the surgical team for positioning. Blood pressure and pulse values will be recorded after the procedure and at the 30th minute of surgery. After the patients wake up, another anesthesiologist in the recovery unit will rate the pain of patients in both groups on a scale of 0-10, using the Visual Analogue Scale (VAS) to describe their pain intensity. Heart rates and noninvasive blood pressures of patients taken to the recovery unit will be measured and recorded.

Eligibility Criteria

• Age: 18 Years - 65 Years
• Gender Eligibility Details: All genders will be included this study
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Patients over the age of 18 and under the age of 65 who will undergo hip arthroscopy

You may qualify if:

• Patients over the age of 18 and under the age of 65 who will undergo hip arthroscopy
• ASA I-II group patients
• Patients without allergies
• Patients without psychiatric disorders
• Patients without opioid addiction
• Patients who have the ability to use the patient-controlled analgesia (PCA) device and perform VAS scoring
• Patients with no contraindications for peripheral blocks

You may not qualify if:

• Patients who do not want to participate in the study
• Patients with uncontrolled hypertension
• Patients with chronic pain or receiving pain treatment,
• Significant Cardiac Disorder (Coronary Artery Disease, Arrhythmia, Electrocardiography Anomaly, Heart Failure, etc.)
• Patients with Diabetes Mellitus

Sponsors & Collaborators

• TC Erciyes University: lead

Central Study Contacts

Recep AKSU MD Recep AKSU, MD, Professor

CONTACT

+90 5337461200; raksu@erciyes.edu.tr

Yunus Emre VURAL Dr Dr. Yunus Emre VURAL, Research assistant

CONTACT

+90 5063515914; dryemrevural@gmail.com

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: PROSPECTIVE
• Target Duration: 1 Day
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Prof. Dr. Recep AKSU

Study Record Dates

• First Submitted: November 1, 2024
• First Posted: November 4, 2024
• Study Start: November 15, 2024
• Primary Completion (Estimated): September 15, 2026
• Study Completion (Estimated): November 15, 2026
• Last Updated: November 4, 2024

Record last verified: 2024-11

Data Sharing

• IPD Sharing: Will not share